FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003302711> ?p ?o ?g. }

• W2003302711 endingPage "51" @default.
• W2003302711 startingPage "39" @default.
• W2003302711 abstract "Today reconstructed skin models that simulate human skin, such as Episkin, are widely used for safety or efficacy pre-screening. Moreover, they are of growing interest for regulatory purposes in the framework of alternatives to animal testing. In order to reduce and eventually replace results of in vivo genotoxicity testing with in vitro data, there is a need to develop new complementary biological models and methods with improved ability to predict genotoxic risk. This can be achieved if these new assays do take into account exposure conditions that are more relevant than in the current test systems. In an attempt to meet this challenge, two new applications using a human reconstructed skin model for in vitro genotoxicity assessment are proposed. The skin is the target organ for dermally exposed compounds or environmental stress. Although attempts have been made to develop genotoxicity test procedures in vivo on mouse skin, human reconstructed skin models have not been used for in vitro genotoxicity testing so far, although they present clear advantages over mouse skin for human risk prediction. This paper presents the results of the development of a specific protocol allowing to perform the comet assay, a genotoxicity test procedure, on reconstructed skin. The comet assay was conducted after treatment of Episkin with UV, Lomefloxacin and UV or 4-nitroquinoline-N-oxide (4NQO). Treatment with the sunscreen Mexoryl was able to reduce the extent of comet signal. A second approach to use reconstructed epidermis in genotoxicity assays is also proposed. Indeed, the skin is a biologically active barrier driving the response to exposure to chemical agents and their possible metabolites. A specific co-culture system (Figure 1) using Episkin to perform the regular micronucleus assay is presented. Micronucleus induction in L5178Y cells cultured underneath Episkin was assessed after treatment of the reconstructed epidermis with mitomycin C, cyclophosphamide or apigenin. This second way of using human reconstructed skin for genotoxicity testing aims at improving the relevance of exposure conditions in in vitro genotoxicity assays for dermally applied compounds." @default.
• W2003302711 created "2016-06-24" @default.
• W2003302711 creator A5006593463 @default.
• W2003302711 creator A5032021807 @default.
• W2003302711 creator A5064710464 @default.
• W2003302711 creator A5077075157 @default.
• W2003302711 creator A5079016283 @default.
• W2003302711 creator A5081458575 @default.
• W2003302711 creator A5083672933 @default.
• W2003302711 date "2006-07-01" @default.
• W2003302711 modified "2023-10-17" @default.
• W2003302711 title "Development of genotoxicity test procedures with Episkin®, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds?" @default.
• W2003302711 cites W129251135 @default.
• W2003302711 cites W1968888104 @default.
• W2003302711 cites W1979770954 @default.
• W2003302711 cites W1981326901 @default.
• W2003302711 cites W1981712944 @default.
• W2003302711 cites W1985113852 @default.
• W2003302711 cites W1993043079 @default.
• W2003302711 cites W2014132949 @default.
• W2003302711 cites W2016588202 @default.
• W2003302711 cites W2024160555 @default.
• W2003302711 cites W2031008845 @default.
• W2003302711 cites W2032580699 @default.
• W2003302711 cites W2032751799 @default.
• W2003302711 cites W2046393507 @default.
• W2003302711 cites W2049921327 @default.
• W2003302711 cites W2050214923 @default.
• W2003302711 cites W2054386186 @default.
• W2003302711 cites W2056077906 @default.
• W2003302711 cites W2063666683 @default.
• W2003302711 cites W2069177031 @default.
• W2003302711 cites W2074561387 @default.
• W2003302711 cites W2075400410 @default.
• W2003302711 cites W2079153899 @default.
• W2003302711 cites W2090678389 @default.
• W2003302711 cites W2091720683 @default.
• W2003302711 cites W2092629964 @default.
• W2003302711 cites W2093989570 @default.
• W2003302711 cites W2098086229 @default.
• W2003302711 cites W2100858306 @default.
• W2003302711 cites W2103797279 @default.
• W2003302711 cites W2109773433 @default.
• W2003302711 cites W2114090345 @default.
• W2003302711 cites W2125435889 @default.
• W2003302711 cites W2126902508 @default.
• W2003302711 cites W2135851757 @default.
• W2003302711 cites W2145187722 @default.
• W2003302711 cites W2145718664 @default.
• W2003302711 cites W2147528374 @default.
• W2003302711 cites W2147667230 @default.
• W2003302711 cites W2147968966 @default.
• W2003302711 cites W2160456500 @default.
• W2003302711 cites W2162213622 @default.
• W2003302711 doi "https://doi.org/10.1016/j.mrgentox.2006.02.009" @default.
• W2003302711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16675293" @default.
• W2003302711 hasPublicationYear "2006" @default.
• W2003302711 type Work @default.
• W2003302711 sameAs 2003302711 @default.
• W2003302711 citedByCount "64" @default.
• W2003302711 countsByYear W20033027112012 @default.
• W2003302711 countsByYear W20033027112013 @default.
• W2003302711 countsByYear W20033027112014 @default.
• W2003302711 countsByYear W20033027112015 @default.
• W2003302711 countsByYear W20033027112016 @default.
• W2003302711 countsByYear W20033027112017 @default.
• W2003302711 countsByYear W20033027112018 @default.
• W2003302711 countsByYear W20033027112019 @default.
• W2003302711 countsByYear W20033027112020 @default.
• W2003302711 countsByYear W20033027112022 @default.
• W2003302711 countsByYear W20033027112023 @default.
• W2003302711 crossrefType "journal-article" @default.
• W2003302711 hasAuthorship W2003302711A5006593463 @default.
• W2003302711 hasAuthorship W2003302711A5032021807 @default.
• W2003302711 hasAuthorship W2003302711A5064710464 @default.
• W2003302711 hasAuthorship W2003302711A5077075157 @default.
• W2003302711 hasAuthorship W2003302711A5079016283 @default.
• W2003302711 hasAuthorship W2003302711A5081458575 @default.
• W2003302711 hasAuthorship W2003302711A5083672933 @default.
• W2003302711 hasConcept C143425029 @default.
• W2003302711 hasConcept C150903083 @default.
• W2003302711 hasConcept C178790620 @default.
• W2003302711 hasConcept C185592680 @default.
• W2003302711 hasConcept C207001950 @default.
• W2003302711 hasConcept C2777459323 @default.
• W2003302711 hasConcept C2778959862 @default.
• W2003302711 hasConcept C2780358455 @default.
• W2003302711 hasConcept C29730261 @default.
• W2003302711 hasConcept C33070731 @default.
• W2003302711 hasConcept C33618052 @default.
• W2003302711 hasConcept C41008148 @default.
• W2003302711 hasConcept C54355233 @default.
• W2003302711 hasConcept C552990157 @default.
• W2003302711 hasConcept C70721500 @default.
• W2003302711 hasConcept C86803240 @default.
• W2003302711 hasConceptScore W2003302711C143425029 @default.
• W2003302711 hasConceptScore W2003302711C150903083 @default.
• W2003302711 hasConceptScore W2003302711C178790620 @default.

• next